Professor Andrew Barbour specialises in the treatment of oesophageal, gastric, and pancreatic diseases, as well as melanoma and soft tissue tumours. He is a Surgical Oncologist at The University of Queensland with a research interest in the treatment of cancer.
As a clinical researcher, he has been active in the conduct of clinical trials at Phase I, II and III levels. He is the Principal Investigator for investigator initiated, multicentre phase II trials in oesophageal (DOCTOR trial) and pancreatic cancer (GAP Trial), funded by the NH&MRC and sponsored by the Australasian Gastrointestinal Trials Group. These studies are aimed at developing personalized, precision therapy for cancer.